U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090824) titled 'Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes' on July 21.
Brief Summary: The SPEED study is a randomized, crossover pilot study evaluating the pharmacokinetics of novel insulin formulations in adults with type 1 diabetes. The study compares two experimental insulin formulations (diluted U-200 Humalog and U-500 Humulin with sterile water, mannitol and EDTA) against commercially available U-100 Lyumjev to determine if these modifications can improve insulin onset and duration of action.
Twenty participants will complete three study visits, each separated by at least48 hours. ...